Joslin Diabetes Center Inc
Joslin Diabetes Center Inc is a public charity based in Charlestown, Massachusetts. Its website describes a mission to prevent, treat, and cure diabetes through research, clinical care, and education; its 2025 filing reports grants to a clinic and to research partners.
Joslin Diabetes Center Inc at a glance
In short: Joslin Diabetes Center Inc gave $11.1M across 23 grants in 2025 (avg $482K), mostly in Massachusetts. Source: 2025 IRS Form 990.
- Annual giving (2025)
- $11,078,364
- +15.4% vs 2024
- Grants made (2025)
- 23
- +43.8% vs 2024
- Average grant
- $481,668
- -19.7% vs 2024
- Median grant
- $84,655
- Total assets
- $182,656,365
- +3.3% vs 2024
- Primary geography
- Massachusetts (78% of itemized 2025 grant dollars)
- Latest 990 filing
- Form 990, 2025 View filing
Data from IRS Form 990, 2025; updated October 2026.
How to apply to Joslin Diabetes Center Inc
- Contact
Mailing address: Co Bilh Tax 529 Main St 4Th Fl, Charlestown, MA 02129
Phone: (781) 744-8924
Website: https://joslin.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who Joslin Diabetes Center Inc funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was Joslin Clinic Inc ($7.1M). Together the top 10 received $10.5M.
Grant Size Distribution
87 grants across all recorded years
The most common grant size was under $50K: 38 grants of 87 (44%).
Geographic Focus
Where this funder awards grants
The 2025 filing reports that 78% of grant dollars went to recipients in Massachusetts, 5% to Michigan, and 3% each to Maine, Pennsylvania, and California. Listed recipients also included organizations in Virginia, Alabama, Florida, Utah, and other states.
Grant Distribution by State
Share of 2025 grant dollars across all 23 itemized grants.
States
Cities
How Joslin Diabetes Center Inc gives
Estimate from itemized grant lists in IRS Form 990 filings (2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2019 to 2025, annual grant giving ranged from $9.6M (2024) to $15.2M (2022). In 2025 it made 23 grants totaling $11.1M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Joslin Clinic Inc Boston, MA | Program Support | $7,084,449 |
| Brigham & Women's Hosp Boston, MA | Research-Subaward | $657,684 |
| Regents of University of Michigan Ann Arbor, MI | Research-Subaward | $576,235 |
| Massachusetts General Hosp Boston, MA | Research-Subaward | $432,211 |
| Beth Israel Lahey Health Inc Boston, MA | Research-Subaward | $379,356 |
| Jackson Laboratory Bar Harbor, ME | Research-Subaward | $292,461 |
| University of Pennsylvania Philadelphia, PA | Research-Subaward | $288,803 |
| Stanford Univ Los Angeles, CA | Research-Subaward | $288,670 |
| University of Virginia Charlottesville, VA | Research-Subaward | $277,598 |
| University of Alabama at Birmingham Birmingham, AL | Research-Subaward | $199,642 |
Ready to take the next step with Joslin Diabetes Center Inc?
Financial History
Multi-year comparison from IRS filings
Joslin’s 2024 filing states that endowment funds are to be used for purposes designated by donors, including general use, clinic support, and research support.
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2025 | $182,656,365 | $77,259,482 | $88,177,463 | $11,078,364 | 23 | $3,167,475 |
| 2024 | $176,840,438 | $71,591,609 | $81,626,334 | $9,600,909 | 16 | $3,443,232 |
| 2023 | $166,005,908 | $74,197,360 | $82,769,482 | $11,406,947 | 18 | $1,623,500 |
| 2022 | $158,601,430 | $134,166,466 | $98,047,633 | $15,241,281 | 29 | $4,718,715 |
| 2021 | $119,817,710 | $81,813,666 | $90,420,592 | $10,148,775 | 1 | $1,784,267 |
| 2020 | $107,556,453 | $76,953,905 | $96,451,661 | $14,836,872 | 1 | $926,976 |
| 2019 | $116,544,681 | $80,200,703 | $94,714,085 | $10,418,645 | 1 | $1,435,690 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
Joslin’s stated mission is to prevent, treat, and cure diabetes, with a vision of a world free of diabetes and its complications. Its research areas include clinical, behavioral, and outcomes research; genetics and epidemiology; immunobiology; integrative physiology and metabolism; islet cell and regenerative biology; pathophysiology and molecular pharmacology; and vascular cell biology.
The 2025 filing lists grants primarily for program support and research subawards. Examples of supported organizations include the Trustees of the University of Pennsylvania, which describes its mission as providing education, pioneering research, and patient care; the University of Miami, which describes itself as a comprehensive research university with programs including medicine and scientific research; the University of Chicago, which describes a mission of creating and communicating knowledge and fostering a scholarly community; and Harvard College, which describes its work as education and research across academic fields.
Grantmaking
In filing year 2025, Joslin reported 23 grants totaling $11,078,364. Grant amounts ranged from $6,846 to $7,084,449, with a median of $84,655. Its largest listed grant was $7,084,449 to Joslin Clinic Inc. for program support. Other large grants included $657,684 to Brigham & Women’s Hospital and $576,235 to the Regents of the University of Michigan, both for research subawards. Additional research-subaward recipients included Massachusetts General Hospital ($432,211), Beth Israel Lahey Health Inc. ($379,356), Jackson Laboratory ($292,461), and the University of Pennsylvania ($288,803).
Joslin’s Diabetes Research Center website describes a Pilot and Feasibility program that awards two grants of up to $50,000 per year for two years. The program is intended to support new or innovative diabetes-related research and has historically served new investigators, experienced investigators pursuing a novel direction, and investigators entering diabetes research from other fields. The website describes a yearly competitive process and eligibility that includes researchers at Joslin or neighboring institutions within Harvard Medical School.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2025 filing lists Roberta Herman as President and Trustee; Martin Pasqualini as Trustee and Chair; and Peter Healy, George L. King, and Sanjeev Mehta as trustees with executive roles. Other listed trustees are Todd Abbrecht, Christine Bray, Michael K. Devlin, Ryan Enright, and Anne M. Lagasse.
Joslin Diabetes Center Inc is led by Tabb Md Kevin, CEO since 2023 (on filings since 2022); 11 of 32 officers listed in 2025 are compensated.
Officers on the 2025 filing
Tabb Md Kevin
CEO
CEO & Bilh President → CEO, 2023
On filings since 2022
1 hr/week
No compensation reported
Herman Md Phd Roberta
President & Trustee
President, CEO & Trustee → President & Trustee, 2023
On filings since 2022
55 hrs/week
$715K (2022) → $950K (2025)
Pasqualini Martin
Trustee & Chair
Vice Chairman & Trustee → Trustee & Chair, 2024
On filings since 2022
1 hr/week
No compensation reported
King Md George L.
Trustee Exoff & Senior Vice President Chief Scientific Officer
Trustee, Senior Vice President & Cso → Trustee & Chief Scientific Officer, 2023
Trustee & Chief Scientific Officer → Trustee Exoff & Senior Vice President Chief Scientific Officer, 2025
On filings since 2022
55 hrs/week
$433K (2022) → $454K (2025)
Mehta Md Sanjeev
Trustee, Senior Vice President, CMO, Cmio & Chf Qual Officer
Trustee → Trustee, Senior Vice President, CMO, Cmio, General & Epi, 2023
Trustee, Senior Vice President, CMO, Cmio, General & Epi → Trustee, Senior Vice President, CMO, Cmio & Chf Qual Officer, 2024
On filings since 2022
55 hrs/week
$284K (2023) → $316K (2025)
Abbrecht Todd
Trustee
On filings since 2022
1 hr/week
No compensation reported
Devlin Michael K.
Trustee
On filings since 2022
1 hr/week
No compensation reported
Lagasse Anne M.
Trustee
Chairman & Trustee → Chair & Trustee, 2023
Chair & Trustee → Trustee, 2025
On filings since 2022
1 hr/week
No compensation reported
Moses Md Alan
Trustee
On filings since 2022
1 hr/week
No compensation reported
Welo Kristen
Trustee
On filings since 2022
1 hr/week
No compensation reported
Polonsky Md Kenneth
Trustee
On filings since 2023
1 hr/week
No compensation reported
Wing Leverett
Trustee
On filings since 2023
1 hr/week
No compensation reported
Enright Ryan
Trustee
On filings since 2024
1 hr/week
No compensation reported
Healy Peter
Trustee
On filings since 2024
1 hr/week
No compensation reported
Sanna Phd Bastiano
Trustee
On filings since 2024
1 hr/week
No compensation reported
Yee Shunee
Trustee
On filings since 2024
1 hr/week
No compensation reported
Bray Christine
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
Meininger Md Gary
Trustee
New on the 2025 filing
1 hr/week
No compensation reported
Aiello Phd Lloyd-Paul
Former Vice President & Opthamology
On filings since 2022
$402K (2022) → $402K (2025)
Bhogadi Satish
Assistant Treasurer & CFO
Assistant Treasurer & Assistant CFO → Assistant Treasurer & CFO, 2025
On filings since 2022
1 hr/week
$220K (2024) → $0 (2025)
Kahn Md Ronald C.
Chief Academic Officer
On filings since 2022
55 hrs/week
$439K (2022) → $412K (2025)
Lit Susan
Chief Operating Officer
On filings since 2023
55 hrs/week
$302K (2023) → $386K (2025)
Sharuk Md George S.
Ophthalmologist
On filings since 2024
55 hrs/week
$316K (2024) → $333K (2025)
Sun Md Mph Jennifer K.
Chief, Center Eye Research & Trials
On filings since 2024
55 hrs/week
$399K (2024) → $650K (2025)
Schaffer Md Jean E.
Senior Investigator & Associate Research Director
New on the 2025 filing
55 hrs/week
$302K (2025)
Schlossman Md Deborah
Ophthalmologist
New on the 2025 filing
55 hrs/week
$297K (2025)
Williams Md Mark
Nephrologist
New on the 2025 filing
55 hrs/week
$291K (2025)
Katz Esq Jamie
Clerk & Bilh General Counsel
Clerk & Bilh General Counsel → Clerk & General Counsel Bilh, 2023
Clerk & General Counsel Bilh → Clerk & Bilh General Counsel, 2025
On filings since 2022
1 hr/week
No compensation reported
Rios Cindy
Treasurer
On filings since 2023
1 hr/week
No compensation reported
Francioli Carl
Treasurer Ex-Officio, Bilh Intrm CFO & Bstn CFO
New on the 2025 filing
1 hr/week
No compensation reported
Herndon Mba Cpa Fache Scott
Treasurer
New on the 2025 filing
1 hr/week
No compensation reported
McIntire Esq William
Assistant Clerk
New on the 2025 filing
1 hr/week
No compensation reported
Former officers (57)
- Former: Armstrong Esq Emily (2022–2024) — Assistant Clerk
- Former: Buckley Esq Maria D. (2022–2024) — Former Clerk & General Counsel
- Former: Rowan Michael (2022–2024) — Trustee Executive Vice President Hos & Amb Bilh
- Former: Halprin Md Elizabeth (2024) — Section Chief & Adult Diabetes
- Former: Hamdy Md Mph Osama (2024) — Phys, Endocrine, Diabetes & Metabolism
- Former: Larrabee Md Joan (2024) — Phys, Endocrine, Diabetes & Metabolism
- Former: Cote Elizabeth R. (2022–2023) — Chief Development Officer
- Former: Kerndl John (2022–2023) — Treasurer
- Former: Lurier Eliot M. (2022–2023) — Former CFO & Treasurer
- Former: Peterson James L. (2022–2023) — Trustee
- Former: Rehnert Geoffrey S. (2022–2023) — Trustee
- Former: Russell Mark E. (2022–2023) — Trustee
- Former: Shaheen Stefany (2022–2023) — Trustee
- Former: D'errico Matthew (2023) — Chief Information Officer
- Former: Difiore David C. (2023) — Vice President Clinical Services
- Former: Harpel Sharon (2023) — Vice President Office Sponsored Research
- Former: O'Donnell Deborah F. (2023) — Director, Proj Management & Process Improvement
- Former: Arrigg Paul (2022) — Chief & Vitriorenal
- Former: Dacey Susan (2022) — Trustee
- Former: Healy Joseph M. (2022) — Chief Strategy Officer
- Former: Hopfield Phd Jessica (2022) — Trustee
- Former: James Ralph M. (2022) — Trustee
- Former: Rubenstein Md Arthur (2022) — Trustee
- Former: Sharuk George (2022) — Ophthalmologist
- Former: Sun Jennifer (2022) — Investigator
- Former: Ann M. Lagasse (2019–2021) — Trustee & Chair
- Former: Arthur Rubenstein Md Mbbch (2019–2021) — Trustee
- Former: Eliot M. Lurier (2019–2021) — Treasurer, CFO & COO
- Former: Geoffrey S. Rehnert (2019–2021) — Trustee
- Former: George L. King MD (2019–2021) — Trustee, Senior Vice President & Chief Science Officer
- Former: George Sharuk (2019–2021) — Ophthalmologist
- Former: James L. Peterson (2019–2021) — Trustee
- Former: Jessica Hopfield Ph D. (2019–2021) — Trustee
- Former: Lloyd P. Aiello (2019–2021) — Vice President & Ophthalmology
- Former: Maria D. Buckley (2019–2021) — General Counsel
- Former: Mark E. Russell (2019–2021) — Trustee
- Former: Martin Pasqualini (2019–2021) — Trustee
- Former: Michael K. Devlin (2019–2021) — Trustee
- Former: Paul G. Arrigg (2019–2021) — Chief & Vitriorenal
- Former: Peter S. Amenta MD (2019–2021) — Former President & CEO
- Former: Ralph M. James (2019–2021) — Trustee
- Former: Robert Gabbay Md Ph D. (2019–2021) — Former CMO & Senior Vice President
- Former: Roberta Herman MD (2019–2021) — President & Chief Executive Officer
- Former: Ronald C. Kahn (2019–2021) — Vice Chairman, Section Chief & Obesity
- Former: Stefany Shaheen (2019–2021) — Trustee
- Former: Susan Dacey (2019–2021) — Trustee
- Former: Todd Abbrecht (2019–2021) — Trustee
- Former: Jennifer Sun (2020–2021) — Investigator
- Former: Sanjeev Mehta (2020–2021) — Vice President, Chief Med. Info Officer & Cqo
- Former: Deborah Schlossman (2021) — Ophthalmologist
- Former: Elizabeth Cote (2021) — Chief Development Officer
- Former: Mark Williams (2019–2020) — Nephrologist
- Former: Osama Hamdy (2019–2020) — Med. Director, Obesity & Inpatient
- Former: Richard A. Smith (2019–2020) — Trustee
- Former: Robert Stanton (2020) — Chief of Nephrology
- Former: Fred Keeton (2019) — Trustee
- Former: John A. Perry (2019) — Vice President & Chief Philanthropy Officer · Filing note: Until 22219
Data from IRS Form 990 filings, 2019–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $950K, to Herman MD PHD Roberta (President & Trustee (Ex-Officio)). 11 officers or directors reported compensation on that filing.
Frequently asked questions about Joslin Diabetes Center Inc
How much does Joslin Diabetes Center Inc give each year?
Joslin Diabetes Center Inc gave $11.1M across 23 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $9.6M across 16 grants.
What is Joslin Diabetes Center Inc's typical grant size?
Joslin Diabetes Center Inc's median grant in 2025 was $84,655, and its average grant was $481,668, across 23 grants on its 2025 IRS Form 990.
Where does Joslin Diabetes Center Inc give grants?
Joslin Diabetes Center Inc gives mostly in Massachusetts: 78% of the grant dollars itemized on its 2025 IRS Form 990 went to recipients there. The next largest state was Michigan (5%). The most frequent recipient cities were Boston, MA (5 grants) and Chicago, IL (2 grants).
Does Joslin Diabetes Center Inc give general operating support?
Not in 2025: none of the 23 grants with a stated purpose on Joslin Diabetes Center Inc's 2025 IRS Form 990 were described as general or operating support. Recurring purposes include "Research-Subaward" (22 grants).
Who are Joslin Diabetes Center Inc's largest grantees?
Joslin Diabetes Center Inc's largest 2025 grantees include Joslin Clinic Inc ($7,084,449), Brigham & Women's Hosp ($657,684) and Regents of University of Michigan ($576,235), according to its 2025 IRS Form 990. Together they received 75% of its itemized 2025 grant dollars.
How large is Joslin Diabetes Center Inc?
Joslin Diabetes Center Inc reported $182.7M in total assets on its 2025 IRS Form 990. Its revenue that year was $77.3M.
What does Joslin Diabetes Center Inc fund?
Joslin’s stated mission is to prevent, treat, and cure diabetes, with a vision of a world free of diabetes and its complications. See mission & focus areas ↑
How do I apply for a grant from Joslin Diabetes Center Inc?
Joslin Diabetes Center Inc has no public application process in the sources Grantable reviewed. Check joslin.org for current guidelines, or contact the foundation directly before submitting a request.
What is Joslin Diabetes Center Inc's EIN?
Joslin Diabetes Center Inc's EIN (Employer Identification Number) is 04-2203836. IRS Form 990 filing data is available on this page for 2019–2025.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(8)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS August 2, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS August 15, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS August 15, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS August 14, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS August 15, 2025)
- Added Form 990 for fiscal year 2019 (received by the IRS August 10, 2020)
- Added Form 990 for fiscal year 2025 (received by the IRS August 14, 2026)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work Joslin Diabetes Center Inc funds
Diseases, Disorders & Medical Disciplines Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in Joslin Diabetes Center Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Alzheimer's Disease & Related Disorders Association Inc
Chicago, IL
The Alzheimer’s Association funds Alzheimer’s and dementia research, including basic, clinical, social and behavioral studies, and supports care, prevention, early detection, awareness, and advocacy. In 2025, its 79 grants ranged from $10,000 to $13.3 million, with a median of $270,750; research opportunities are open to U.S. and international researchers.
Assets
$523.7M
Grants
79
Total Given
$73.3M
The Susan G Komen Breast Cancer Foundation Inc
Dallas, TX
The Susan G. Komen Breast Cancer Foundation funds breast cancer research and programs supporting education, patient navigation, financial assistance, and access to care. Its 2025 grants ranged from $2,681 to $945,992, with a median of $158,660, and it funds work in the United States and 24 other countries. Research applications require an LOI, and full applications are by invitation; whether it accepts unsolicited requests is not stated.
Assets
$178.9M
Grants
61
Total Given
$16.1M
Trustees of Tufts College
Medford, MA
Trustees of Tufts College supports university instruction, research, student services, and related organizations; its 2025 grants had a median of $76,881, though many large awards were subcontract grants. Giving is concentrated in Massachusetts, and its Tufts Community Grants offer $5,000 for eligible nonprofit projects in Boston, Grafton, Medford, and Somerville; the profile does not state whether it accepts unsolicited requests.
Assets
$4.9B
Grants
149
Total Given
$38.3M
Northeastern University
Boston, MA
Northeastern University supports education, student aid, research, and academic and student services, with reported grants identified as sub-awards to universities and other organizations. Its 2025 grants had a median of about $75,000; recipients include organizations in multiple U.S. states, though no geographic grant limits are stated. The application information describes internal programs for Northeastern faculty and students, and does not state whether it accepts unsolicited requests from outside applicants.
Assets
$6.8B
Grants
183
Total Given
$46.1M
Fred Hutchinson Cancer Center
Seatle, WA
Fred Hutchinson Cancer Center funds cancer and infectious disease research, along with Washington community-led projects in cancer prevention, screening, education, and care access. Research grants vary widely (the 2025 median was about $118,000); its community awards were up to $15,000, and Tribal Community Grants up to $50,000 plus indirect costs. Community programs are focused on Washington State; whether unsolicited requests are accepted is not stated.
Assets
$3.6B
Grants
139
Total Given
$88.2M
The Michael J Fox Foundation for Parkinson's Research
New York, NY
The Michael J. Fox Foundation funds basic, translational, and clinical research to advance a cure for Parkinson’s disease and improve treatments, supporting researchers in the United States and internationally. Its 2025 grants had a median award of about $426,000, though amounts varied widely. It generally does not accept unsolicited proposals; applications are submitted through its grant portal for designated funding opportunities.
Assets
$639.2M
Grants
149
Total Given
$201.5M
More similar funders
More Funders in Massachusetts
Cite this profile
Grantable. (2026). Joslin Diabetes Center Inc funder profile. GrantGraph. Retrieved October 18, 2026, from https://grantable.co/funders/joslin-diabetes-center-inc-morg_3f39e9b03d824e1eabec2240f10587eb
BibTeX
@misc{grantable_042203836_2026,
author = {{Grantable}},
title = {{Joslin Diabetes Center Inc funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/joslin-diabetes-center-inc-morg_3f39e9b03d824e1eabec2240f10587eb},
note = {Accessed 2026-10-18. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from Joslin Diabetes Center Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Joslin Diabetes Center Inc down — hundreds of funders to go?